significant loss of myelin integrity has been shown in patients with AD and mild cognitive impairment (MCI) compared to controls measured by diffusion tensor imaging (DTI), 14 and this precedes the onset of cognitive impairment in both healthy aging adults and apolipoprotein E (APOE) ε4 carriers. [15] [16] [17] Recently, it was demonstrated that transgenic AD mice, including triple-transgenic AD mice and APP/PS1 mice, exhibit significant abnormalities in myelination patterns and in the expression profiles of oligodendrocyte markers at subregions of the entorhinal cortex (ERC) and hippocampus. 18, 19 Myelin ensures saltatory conduction of action potentials, which makes it possible to integrate information across spatially distributed neural networks underlying higher cognitive function, 20 such as memory. Preliminary clinical evidence has suggested that the decline in memory is associated with demyelination of neural circuits at AD onset, which is reflected by increases in radial diffusivity (DR) of DTI, especially in the direct or secondary connections to the medial temporal lobe structures, such as parahippocampal white matter (WM), the cingulum, the inferior fronto-occipital fasciculus/ unciform fasciculus, and the splenium of the corpus callosum. 21 However, it was still unknown whether demyelination plays an important role in memory impairment independent of amyloid and tau pathology in AD.
LINGO-1 is an attractive target for remyelination in central nervous system (CNS)
. This protein, selectively expressed on neurons 22, 23 and OLGs 24 in CNS, 22 interacts with the Nogo-66 receptor (NgR) and p75/TROY/TOJ neurotrophic receptor 25 as a negative regulator for OLGs differentiation and myelination, neuronal survival and axonal regeneration. 22, 24 Previous studies found that LINGO-1 and its associated proteins were elevated significantly, 26 and endogenous inhibitors of NgR1 were decreased in hippocampus of aged rats with impaired memory significantly. 27 And some researches have shown that LINGO-1 antagonists increase the expression and phosphorylation status of Fyn and decrease the amount of activated RhoA-GTP, thereby promoting differentiation and myelination. 24, 28 Based on this evidence, a human monoclonal antibody directed against LINGO-1 (BIIB033) has been used in subjects with relapsing forms of multiple sclerosis (MS) and acute optic neuritis to enhance CNS remyelination.
In this study, we tested the hypothesis that demyelination might be involved in memorial impairment in 5XFAD mice at early stage of AD. It was shown that myelin injury is an early event in 5XFAD mice prior to emergence of deposition of Aβ and involved in spatial memory deficits, while remyelination with LINGO-1 antibody could attenuate spatial memory deficits.
| METHODS

| Transgenicandwildmice
5XFAD mice co-express human APP and presenilin 1 with five familial AD mutations (APP K670N/M671L + I716V + V717I and PS1 M146L + L286V) were obtained from Jackson Laboratories. 29 The 5XFAD
mice were backcrossed for five generations on the C57BL6/J genetic background in Fujian Medical College. The mice were genotyped using polymerase chain reaction and gel electrophoresis. Only male mice were used for the follow experiments. The experiments used onemonth-old and three-month-old male 5XFAD mice, along with agematched wild-type C57BL6/J mice. All mice were housed in standard 12-h light-dark cycle (lights on at 7:00 am) with free access to food and water, maintained in a temperature (22 ± 2°C) and humidity (50 ± 5%) controlled environment. All protocols and procedures used in the study were approved by the Jiang Su Animal Care and Use Committee.
| GenerationoftheLINGO-1antibody
The protocols were applied referring previous report 30 in the process of generation, identification, and biophysical characterization analysis of murine monoclonal antibody (mAb) to LINGO-1. In brief, the recombinant LINGO-1 (sequence was shown in Figure 1 .) was generated in Escherichia coli and purified on protein A-Sepharose (GenScript Company, China). The antibody to LINGO-1 was generated subsequently as the MonoExpress ™ Gold package service (GenScript Company). The specificity of antibody was tested for combining with the recombinant LINGO-1 using Western Blot (WB), another dC-histagged protein as negative control and serum from the immunized mice with recombinant LINGO-1 as positive control. The specific According to the results of pharmacokinetics in brain of mice ( Figure 2D ), one-month-old 5XFAD mice were administrated LINGO-1
antibody (5XFAD+anti-LINGO-1) every 6 day over 2 months. Dosing solution was prepared in saline at 3 mg/mL and administered to mice at 1 mL/kg via subcutaneous injection. Another group one-month-old 5XFAD and wild mice were administrated with saline. Our previous study also revealed that the concentration of the antibody could promote remyelination and recovery of motor and cognitive function in experimental autoimmune encephalomyelitis and cuprizone-fed demyelated mice separately 31,32
| Morriswatermazetest(MWM)
Our MWM has been described elsewhere. 31 Briefly, the maze was a 1.2-m-diameter circular pool filled with opaque water (22°C) addicted by nontoxic, water-based white food coloring.
A circular Plexiglas escape platform (6 cm in diameter) was lo- 
| Transmissionelectronmicroscopy(TEM)
Mice were processed for TEM analysis as description with slight modifications. 1 Brain regions were dissected with a dissecting microscope according to the mouse brain stereotaxic atlas, 33 including 
| WesternBlot(WB)
Tissue samples from different regions of the mice brain were collected, including medial prefrontal cortex (mPFC) (bregma 2.80 to 
| Immunofluorescence
Mice were deeply anesthetized with chloral hydrate and perfused transcardially with saline followed by 4% paraformaldehyde. The animals' brains were removed, postfixed with 4% paraformaldehyde overnight and followed by 10%, 20%, and 30% sucrose solu- Images were captured with a fluorescence microscope equipped with 10 × objectives.
| Statisticalanalysis
All values were presented as the means ± standard error (S.E.M). Data from acquisition trials of MWM was analyzed with two-way repeated-measures analysis of variance (ANOVA) with Student's t-test was used between two groups, and one-way ANOVA was used among three groups followed by Holm-Sidak's multiple comparisons as post hoc test (GraphPad Prism 6.07).
Correlation analysis was conducted with Pearson's correlation (GraphPad Prism 6.07). Statistical significance was established at P < 0.05.
| RESULTS
| ThecharacterizationofLINGO-1monoclonal antibody
As shown in Figure 2A , the monoclonal antibody could bind recombined LINGO-1 protein specially. It was purified to 93% and efficiently reduced endotoxin levels to ≤3 EU/mg. Binding curves and concentration for EC50 are shown in Figure 2C . The pharmacokinetics in brain of mouse were shown in Figure 2D . The lowest concentration of the antibody was much higher than EC50 (3.289e-4 μg/μL), and 144 h was chosen as the interval of administration.
| DepositionofAßinthree-month-old 5XFADmice
The deposition of Aß was not found in one-month-old 5XFAD mice, but shown in three-month-old 5XFAD mice in both hippocampus and entorhinal cortex (Figure 3 ).
| Impairmentsofmemoryinone-month-old 5XFADmiceandimprovementatthree-month-old administratedwithLINGO-1antibody
In the MWM test, one-month-old 5XFAD mice showed a significant decrease in the percentage of the time spent on the quadrant (t = 2.790, P = 0.005, Figure 4C ) and the crossovers of platform (t = 3.000, P = 0.004, Figure 4D ) compared with controls, whereas no significant difference in swimming velocity ( Figure 4B ). In addition, there was no significant difference in the escape latency in the five training days ( Figure 4A ). Compared with controls group, threemonth-old 5XFAD mice significantly prolonged the escape latency to find the hidden platform at the third day (t = 2.823, P = 0.016),
while it tended to improve with anti-LINGO-1 treatment ( Figure 5A ).
In the probe trial of MWM test, there was distinct difference in the percentage of the time spent on the quadrant (F = 3.426, P = 0.041, Figure 5C ) and the crossovers of platform (F = 4.801, P = 0.013, Figure 5D ). Three-month-old 5XFAD mice significantly decreased the percentage of the time spent on the quadrant (P = 0.046, Figure 5C ) and the crossovers of platform (P < 0.001, Figure 5D) without abnormal swimming velocity ( Figure 5B ) compared with age-matched controls. While anti-LINGO-1 treatment for 5XFAD mice had a significant ameliorative effect on crossovers (t = 9.4, P < 0.001, Figure 5D ) and ameliorative trend in the time spent on the quadrant ( Figure 5C ). Meanwhile, the g-ratio was also increased in PrL, CA1, and ERC
(Figure 8). After anti-LINGO-1 treatment, one-way ANOVA analysis
showed the difference in the percentage of aberrant myelinated axons of three different groups and g-ratio ( Figure 9 ). LINGO-1 antibody could increase g-ratio and reduce aberrant myelinated axons.
| ThepotentialrelationshipofMBP/ LINGO-1andmemory
There was positive correlation between increased DG LINGO-1 expression, decreased MBP expression, and deficits of spatial memory ( Figure 10 ).
| DISCUSSION
The present study has demonstrated demyelination in an animal model of early AD. Furthermore, spatial memory was found to be impaired in 5XFAD mice at 1 month old and deteriorated with age, which was correlated with demyelination. We also find that administration of an antibody against LINGO-1 could reverse the impairments of myelin in some brain regions involved in memory and improve memory function of 5XFAD mice. Our results suggested that myelin injury was involved in spatial memory deficits and remyelination may be a potential therapeutic strategy in early stage of AD. the earliest amyloid deposition started at 2 months. 29 We also found there was no amyloid pathology at 1 month old in 5XFAD mice. In addition, the concentrations of synaptophysin in the whole brain decrease from 4 months 29 and Ser396 tau phosphorylation is significantly higher than wild-type mice at age ranging from 2 to 6 months in 5XFAD mice. 34 However, we found that spatial memory retrieval is impaired in one-month-old mice prior to the emergence of classical pathological markers for AD (amyloid deposition, tau pathologies, and degeneration of synapses). Impairment of learning ability in acquisition trials emerged from 3 months of age, which was later than memorial impairments. There were no motor disabilities for explaining the behavioral abnormalities.
It was shown that abnormalities of myelin occur in different AD mouse models in early stage. These include partially or completely lost myelin sheath within the WM in PDAPP mice at 2 months of age 35 and myelination defects within subregions of the ERC and hippocampus in two-month-old 3 × Tg-AD mice.
18
And in clinical study with diffusion tensor imaging, it was also
shown that abnormal integrity of myelin concentrated on genu of the corpus callosum, the medial temporal lobe, and their connections in APOEε4 carriers without symptoms, 15, 17, 36 Consistent with previous studies, we found the increased abnormal myelinated axons, rising g-ratio, and decreased MBP in 5XFAD mice at 1 month of age in our study, which is prior to the emergence of classical pathological markers for AD. Combining with previous studies, our results firmly suggested that myelin injury was an early event in AD. Many studies have demonstrated that myelination is involved in cognition formation. Diffusion tensor imaging shows that abnormal integrity of myelin concentrated on regions of limbic system, prefrontal lobe, and their connections were involved and aggravated in patients with cognitive impairments. 40 Our previous study also revealed that demyelination of the parahippocampal cortex (PHC) and fimbria-fornix may contribute to the cognitive impairment in experimental autoimmune encephalomyelitis mice, and the LINGO-1 antibody ameliorates the spatial memory deficits by promoting remyelination in the PHC. 31 In the present study, we found myelin injury in one-month-old 5XFAD mice, and the loss of MBP and increase of LINGO-1 correlated with spatial memory ability, which is consisted with earlier report. 26 Furthermore, the Therefore, further comprehensive studies are needed to estimate the role of demyelination at AD onset and to assess intervention aimed at reversing the demyelination.
